Found 6 matching trials
Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors
PHASE1This is a Phase I, open-label, multi-center trial designed to evaluate the ...
Location
UCSF School of Medicine
Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients With MYC Alterations
PHASE2This is a Phase 2, open-label, multicenter trial designed to evaluate the e...
Location
University of California San Francisco-Fresno
CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer
PHASE2Background:
The thyroid is a gland at the base of the throat. Thyroid canc...
Location
National Institutes of Health Clinical Center
Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
PHASE1This research study is evaluating a novel drug called CUDC-907 as a possibl...
Location
University of California, San Francisco, Benioff Children's Hospital
Fimepinostat in Treating Brain Tumors in Children and Young Adults
EARLY_PHASE1This trial studies how well fimepinostat works in treating patients with ne...
Status
Active Not Recruiting
Location
Children's Hospital Los Angeles (CHLA)
Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma
PHASE1This is a phase 1, open-label, dose-escalation study of fimepinostat (CUDC-...
Location
USC/Norris Comprehensive Cancer Center